Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Phase II Clinical Trial of Personalized-VCD-VTD Sequential Therapy Using VES-13 for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Tomonori Nakazato, MD PhD, Masao Hagihara, Seiji Irie, Naohi Sahara, Eri Tanaka, Yotaro Tamai, Ryuji Ishii, Shigehisa Tamaki, Atsushi Wake, MD PhD, Kenji Tajika, Rika Sakai, MD PhD, Takeshi Kobayashi, MD, Fumiya Sano, Takayuki Abe, Rachel Roberts, Shin Fujisawa, MD PhD, Koji Miyazaki, Masaaki Higashihara

Blood (2017) 130 (Supplement 1): 3162.

https://doi.org/10.1182/blood.V130.Suppl_1.3162.3162

Published: 2017

Journal Articles

Protection of Transplanted Hematopoietic Stem Cells from Inflammatory Recipient Marrow Environment through Specific TNF-α Signal Blockade

Takashi Ishida, MD, Sachie Suzuki, MD, Chen-Yi Lai, PhD, Masaaki Higashihara, MD, PhD, Hiromitsu Nakauchi, MD PhD, Makoto Otsu, MD, PhD

Blood (2015) 126 (23): 1867.

https://doi.org/10.1182/blood.V126.23.1867.1867

Published: 2015

Journal Articles

Proof of Benefit in Multiple-Cord Blood Transplantation Evidenced By Early Hematopoietic Reconstitution

Takashi Ishida, MD, Satoshi Takahashi, MD,PhD, Chen-Yi Lai, PhD, Masaaki Higashihara, MD, PhD, Hiromitsu Nakauchi, MD PhD, Makoto Otsu, MD, PhD

Blood (2015) 126 (23): 3071.

https://doi.org/10.1182/blood.V126.23.3071.3071

Published: 2015

Journal Articles

A New Strategy to Overcome the Cell Dose Barrier to Umbilical Cord Blood Transplants: A Proof of Early Hematopoietic Reconstitution By Combined Multiple Units of Allogeneic Stem/Progenitor Cells

Takashi Ishida, MD, Makoto Otsu, MD PhD, Satoshi Takahashi, MD PhD, Masaaki Higashihara, MD PhD, Hiromitsu Nakauchi, MD PhD

Blood (2014) 124 (21): 3810.

https://doi.org/10.1182/blood.V124.21.3810.3810

Published: 2014

Journal Articles

Detection of Anti-Thrombopoietin Antibodies in Patients with Immune Thrombocytopenia

Takashi Satoh, PhD, Koji Miyazaki, MD PhD, Naoki Shimada, Koki Nagane, Tomoya Inukai, Hayato Nakajima, Masaaki Higashihara, MD PhD, Shinichiro Takahashi, MD PhD

Blood (2014) 124 (21): 4187.

https://doi.org/10.1182/blood.V124.21.4187.4187

Published: 2014

Journal Articles

Rituximab As Second-Line Treatment For Chronic Immune Thrombocytopenia: Investigator-Initiated Clinical Trial In Japan

Yoshitaka Miyakawa, MD, PhD, Shinya Katsutani, MD, PhD, Takahiro Yano, MD, PhD, Shosaku Nomura, MD, PhD, Kaichi Nishiwaki, MD, Yoshiaki Tomiyama, MD, PhD, Masaaki Higashihara, MD, PhD, Yukari Shirasugi, MD, PhD, Masakatsu Nishikawa, MD, PhD, Katsutoshi Ozaki, MD, PhD, Kayoko Kikuchi, Takayuki Abe, PhD, Yuji Sato, MD, PhD, Yuzuru Kanakura, Kingo Fujimura, MD, PhD, Yasuo Ikeda, MD, PhD, Shinichiro Okamoto, MD, PhD

Blood (2013) 122 (21): 3554.

https://doi.org/10.1182/blood.V122.21.3554.3554

Published: 2013

Journal Articles

Fcγ receptor IIB gene polymorphism in adult Japanese patients with primary immune thrombocytopenia

Takashi Satoh, Koji Miyazaki, Asako Shimohira, Naoki Amano, Yuka Okazaki, Tetsuya Nishimoto, Tohru Akahoshi, Shinichi Munekata, Yuhsaku Kanoh, Yasuo Ikeda, Masaaki Higashihara, Shinichiro Takahashi, Masataka Kuwana

Blood (2013) 122 (11): 1991–1992.

https://doi.org/10.1182/blood-2013-05-501858

Published: 2013

Includes: Supplemental data

Journal Articles

The Immature Platelet Fraction Is Sensitive to the Platelet Size and a Useful Parameter for Screening for Macrothrombocytopenia

Koji Miyazaki, MD, PhD, Yukako Koike, MD, PhD, Mikio Danbara, MD, PhD, Ryouichi Horie, MD, PhD, Masaaki Higashihara, M.D., PhD.

Blood (2012) 120 (21): 1097.

https://doi.org/10.1182/blood.V120.21.1097.1097

Published: 2012

Journal Articles

Inhibition of NF-κB Activation Augments the Effect of 5-Azacytidine On Acute Myeloid Leukemia Cell Line

Tomiteru Togano, MD, PhD, Makoto Nakashima, MS, Mariko Watanabe, PhD, Kazuo Umezawa, PhD, Toshiki Watanabe, MD, PhD, Masaaki Higashihara, M.D., PhD., Ryouichi Horie, MD, PhD

Blood (2012) 120 (21): 1369.

https://doi.org/10.1182/blood.V120.21.1369.1369

Published: 2012

Journal Articles

MYL9 Is Prerequisite for the CD3 Expression in Cytoplasm Membrane of T Lymphocytes

Takumi Aoki, M.D., Koji Miyazaki, MD, PhD, Masaaki Higashihara, M.D., PhD.

Blood (2011) 118 (21): 4925.

https://doi.org/10.1182/blood.V118.21.4925.4925

Published: 2011

Journal Articles

Associations of Aberrant T Cell Antigen Expression on B Cells of Diffuse Large B Cell Lymphoma Patients with Their Background and Prognosis

Yuhko Suzuki, MD, PhD, Tsutomu Yoshida, Hirokazu Kimura, Manabu Ohsaka, Koji Miyazaki, Mikio Danbara, Ryouichi Horie, Yuhichi Satoh, Masaaki Higashihara

Blood (2010) 116 (21): 5088.

https://doi.org/10.1182/blood.V116.21.5088.5088

Published: 2010

Journal Articles

Effect of CD20 Expression Levels On B-Cell Lymphoma Patients' Background and Prognosis.

Yuhko Suzuki, MD, Tsutomu Yoshida, MD, Naoya Nakamura, MD, Tomiteru Togano, MD, Koji Miyazaki, MD, Ryuuji Ishii, MD, Manabu Ohsaka, MD, Mikio Danbara, MD, Ryouichi Horie, MD, Meijin Nakayama, MD, Isao Okayasu, MD, Masaaki Higashihara, MD

Blood (2009) 114 (22): 5000.

https://doi.org/10.1182/blood.V114.22.5000.5000

Published: 2009

Journal Articles

Alteration of Circulating Regulatory T Cells in Japanese Adult Patients with Immune Thrombocytopenic Purpura after Eradication of Helicobacter Pylori.

Koji Miyazaki, MD, PhD, Mikio Danbara, Manabu Ohsaka, Yuhko Suzuki, Ryouichi Horie, Masaaki Higashihara

Blood (2008) 112 (11): 3410.

https://doi.org/10.1182/blood.V112.11.3410.3410

Published: 2008

Journal Articles

Use of the Platelet Indices for Differential Diagnosis of Pediatric Immune Thrombocytopenic Purpura (ITP)

Hisaya Nakadate, M.D., Ph.D, Miho Kaida, M.D., Shinsuke Furukawa, M.D., Masahiro Ishii, M.D., Ph.D, Masaaki Higashihara, M.D., Ph.D

Blood (2008) 112 (11): 4557.

https://doi.org/10.1182/blood.V112.11.4557.4557

Published: 2008

Journal Articles

Immature Platelet Fraction in Different Diagnosis of Thrombocytopenic States: An Approach to Distinguish Idiopathic Thrombocytopenic Purpura from Myelodysplastic Syndrome with Isolated Thrombocytopenia.

Koji Miyazaki, MD, PhD, Miyako Taira, PhD, Tomiteru Togano, MD, Manabu Ohsaka, MD, PhD, Yuhko Suzuki, MD, PhD, Mikio Danbara, MD, PhD, Ryouichi Horie, MD, PhD, Masaaki Higashihara, MD, PhD

Blood (2006) 108 (11): 1085.

https://doi.org/10.1182/blood.V108.11.1085.1085

Published: 2006

Journal Articles

Hereditary αδ-Storage Pool Deficiency with the Abnormal Structures of the Platelet Microtubules.

Koji Miyazaki, MD, PhD, Hayato Kawakami, PhD, Masaaki Higashihara, MD, PhD

Blood (2005) 106 (11): 4001.

https://doi.org/10.1182/blood.V106.11.4001.4001

Published: 2005

Journal Articles

Dual targeting of transformed and untransformed HTLV-1–infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia

Mariko Watanabe, Takeo Ohsugi, Momoko Shoda, Takaomi Ishida, Shigemi Aizawa, Masae Maruyama-Nagai, Atae Utsunomiya, Shin Koga, Yasuaki Yamada, Shimeru Kamihira, Akihiko Okayama, Hiroshi Kikuchi, Kimiharu Uozumi, Kazunari Yamaguchi, Masaaki Higashihara, Kazuo Umezawa, Toshiki Watanabe, Ryouichi Horie

Blood (2005) 106 (7): 2462–2471.

https://doi.org/10.1182/blood-2004-09-3646

Published: 2005

Includes: Supplemental data

Journal Articles

Phase I/II Study of the Rituximab-EPOCT Regimen in Combination with G-CSF in Patients with Relapsed or Refractory Follicular Lymphoma Including Evaluation of Its Cardiotoxicity Using B-Type Natriuretic Peptide and Troponin T Levels.

Nozomi Niitsu, M.D., Mika Khori, M.D., Miyuki Hayama, Masaaki Higashihara, M.D., Jun-ichi Tamaru, M.D.

Blood (2004) 104 (11): 4608.

https://doi.org/10.1182/blood.V104.11.4608.4608

Published: 2004

Journal Articles

The E1841K Mutation in MYH-9 of a Patient with May-Hegglin Anomaly Inhibits the Disassembly of Non-Muscle Myosin IIA (MYH-9) Responsible for the Phenotype of the Disease.

Koji Miyazaki, MD, PhD, Satoshi Komatsu, PhD, Mariko Watanabe, Naoya Nakadate, MD, PhD, Mitsuo Ikebe, PhD, Masaaki Higashihara, MD, PhD

Blood (2004) 104 (11): 736.

https://doi.org/10.1182/blood.V104.11.736.736

Published: 2004

NARROW

Phase II Clinical Trial of Personalized-VCD-VTD Sequential Therapy Using VES-13 for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Protection of Transplanted Hematopoietic Stem Cells from Inflammatory Recipient Marrow Environment through Specific TNF-α Signal Blockade

Proof of Benefit in Multiple-Cord Blood Transplantation Evidenced By Early Hematopoietic Reconstitution

A New Strategy to Overcome the Cell Dose Barrier to Umbilical Cord Blood Transplants: A Proof of Early Hematopoietic Reconstitution By Combined Multiple Units of Allogeneic Stem/Progenitor Cells

Detection of Anti-Thrombopoietin Antibodies in Patients with Immune Thrombocytopenia

Rituximab As Second-Line Treatment For Chronic Immune Thrombocytopenia: Investigator-Initiated Clinical Trial In Japan

Fcγ receptor IIB gene polymorphism in adult Japanese patients with primary immune thrombocytopenia

The Immature Platelet Fraction Is Sensitive to the Platelet Size and a Useful Parameter for Screening for Macrothrombocytopenia

Inhibition of NF-κB Activation Augments the Effect of 5-Azacytidine On Acute Myeloid Leukemia Cell Line

MYL9 Is Prerequisite for the CD3 Expression in Cytoplasm Membrane of T Lymphocytes

Associations of Aberrant T Cell Antigen Expression on B Cells of Diffuse Large B Cell Lymphoma Patients with Their Background and Prognosis

Effect of CD20 Expression Levels On B-Cell Lymphoma Patients' Background and Prognosis.

Alteration of Circulating Regulatory T Cells in Japanese Adult Patients with Immune Thrombocytopenic Purpura after Eradication of Helicobacter Pylori.

Use of the Platelet Indices for Differential Diagnosis of Pediatric Immune Thrombocytopenic Purpura (ITP)

Immature Platelet Fraction in Different Diagnosis of Thrombocytopenic States: An Approach to Distinguish Idiopathic Thrombocytopenic Purpura from Myelodysplastic Syndrome with Isolated Thrombocytopenia.

Hereditary αδ-Storage Pool Deficiency with the Abnormal Structures of the Platelet Microtubules.

Dual targeting of transformed and untransformed HTLV-1–infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia

Phase I/II Study of the Rituximab-EPOCT Regimen in Combination with G-CSF in Patients with Relapsed or Refractory Follicular Lymphoma Including Evaluation of Its Cardiotoxicity Using B-Type Natriuretic Peptide and Troponin T Levels.

The E1841K Mutation in MYH-9 of a Patient with May-Hegglin Anomaly Inhibits the Disassembly of Non-Muscle Myosin IIA (MYH-9) Responsible for the Phenotype of the Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only